Cyclin-dependent kinases (CDKs) are critical positive regulators of cell cycle progression and cellular transcription whose dysregulation can lead to the development of cancer. Dinaciclib inhibits CDK1, CDK2, CDK5, and CDK9 activity in vitro with IC50 va
Molecular Weight:
396.49
Purity:
~98%
Form:
Supplied as a crystalline solid.
CAS Number:
[779353-01-4]
* VAT and and shipping costs not included. Errors and price changes excepted